Systematic monitoring identified a high incidence of hypopituitarism following combined ipilimumab plus nivolumab therapy for metastatic melanoma - Top-Institutions - MDSpire

Systematic monitoring identified a high incidence of hypopituitarism following combined ipilimumab plus nivolumab therapy for metastatic melanoma

  • By

  • Mahir Hasan

  • Wolfram Samlowski

  • Samer Nakhle

  • May 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    Melanoma Institute Australia
    Melanoma Institute Australia

    Sydney, NSW

    Key Differentiators

    • Oncology

  • #3

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm

    Key Differentiators

    • Oncology

  • #4

    The University of Sydney
    The University of Sydney

    Sydney, NSW

    Key Differentiators

    • Oncology

Original Source(s)

Systematic monitoring identified a high incidence of hypopituitarism following combined ipilimumab plus nivolumab therapy for metastatic melanoma

  • by Mahir Hasan, Wolfram Samlowski, Samer Nakhle

  • May 8, 2026

Related Content

Dana-Farber Researchers Receive AACR 2026 Scientific Achievement Awards

Dr. Eliezer Van Allen and Dr. Kimberly Stegmaier have been selected by the American Association for Cancer Research (AACR) as recipients of 2026 Scientific Achievement Awards. Both researchers will be honored during the AACR Annual Meeting 2026, held April 17-22 at the San Diego Convention Center.

  • by

  • April 10, 2026

  • 4 min
Factors Influencing the Severity of Pneumonitis Associated with Immune Checkpoint Inhibitors: Insights from Clinical, Radiological, and Laboratory Data in Real-World Settings

The Immune Landscape of Melanoma Microenvironmental Crosstalk